arrow
B

Bahar Artım-Esen

department of internal medicine
H指数:19
被引数:2,164

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluation of echocardiographic features and cardiac biomarkers in patients with AA amyloidosis: a retrospective comparative study with patients with al amyloidosis and hypertrophic cardiomyopathy

评价AA型淀粉样变性患者的心脏超声特征和心脏生物标志物:与AL型淀粉样变性和肥厚型心肌病患者的回顾性比较研究

2026-09-040
PRE
Association of rheumatoid factor with vasculitic manifestations and distinct clinical patterns in eosinophilic granulomatosis with polyangiitis: a multicenter observational study

类风湿因子与嗜酸性肉芽肿性多血管炎中血管炎表现及特定临床模式的相关性:一项多中心观察性研究

2026-06-260
PRE
Predictors of relapse and drivers of damage in SLE-associated thrombocytopenia: a long-term cohort study with comparative literature analysis

系统性红斑狼疮相关性血小板减少症的复发预测因素与损伤驱动因素:一项长期队列研究及比较文献分析

2026-04-200
PRE
Do ethnoracial differences exist among antiphospholipid antibody-positive patients with no other systemic autoimmune diseases: results from the APS ACTION registry

抗磷脂抗体阳性患者中是否存在与种族/民族相关的差异:APS ACTION登记研究的结�<|user|>

2026-04-160
PRE
Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countries

抗磷脂综合征的心血管风险因素控制,以及原发性抗磷脂综合征与系统性红斑狼疮相关抗磷脂综合征(SURF-SLE和APS项目)之间的差异:一项来自11个国家1003例个体的横断面研究

2025-11-190
PRE
Phenotypes of patients with more than one autoinflammatory disease-associated gene variant: overlapping and mixed autoinflammatory disorders

具有多个自身炎症性疾病相关基因变异的患者表型:重叠性及混合性自身炎症性疾病

2025-11-010
PRE
Transient elastography measurements of the liver and transplanted kidney in patients with AA amyloidosis: a cross-sectional comparative study

AA型淀粉样变性患者肝脏和移植肾脏的瞬时弹性成像测量:一项横断面比较研究

2025-07-010
OAAI
Prevalence and target attainment oftraditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries
2024-07-012
PRE
2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
2023-08-28139
PRE